Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-21-043137

Chief Commercial Officer sold 3,625 shares at $89.22 ($323,423)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hassard James Chief Commercial Officer 2021-06-22 Sale −3,625 $89.22 $323,423 105,750 D: show line 1 in the form
Open-market sales · 3,625 sh · avg $89.22 · $323,423
Loading xslF345X03/doc4.xml…